ʻO Sitagliptin Triazole Hydrochloride CAS 762240-92-6 Maʻemaʻe > 99.0% (HPLC) Hale Hana Kiʻekiʻe

ʻO ka wehewehe pōkole:

Ka inoa: Sitagliptin Triazole Hydrochloride

CAS: 762240-92-6

Maʻemaʻe: >99.0% (HPLC)

ʻAno: Keʻokeʻo a i ʻole-White Crystalline Powder

ʻO ka waena o Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9) no ka mālama ʻana i ka maʻi diabetes type II.

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

E-Mail: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Na Waiwai Kemika:

Inoa Kimia 3-(Trifluoromethyl)-5,6,7,8-tetrahydro- [1,2,4] triazolo [4,3-a] pyrazine Hydrochloride
Nā huaʻōlelo like Sitagliptin Triazole Hydrochloride;ʻO Sitagliptin Intermediate A
Helu CAS 762240-92-6
Helu CAT RF-PI1193
Kūlana Kūʻai Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona
ʻĀpana Molekala C6H7F3N4·HCl
Kaumaha Molecular 228.60
Lae hehee 236.0~246.0 ℃
Ka hoʻoheheʻe Hiki ke hoʻoheheʻe ʻia i ka Methanol
Brand Kemika Ruifu

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku Keʻokeʻo a i ka pauka kristal keʻokeʻo
ʻIke ʻia e HPLC ʻO ka manawa paʻa o ka laʻana ua kūlike me ka maʻamau kuhikuhi
ʻIke ʻia e IR Hoʻokō
Nalo ma ka maloo <0.50%
Na mea pili
ʻO kēlā me kēia haumia hoʻokahi <0.50%
Huina paumaele <1.00%
Metala Kaumaha <20ppm
Maʻemaʻe / Kaʻina Hanana >99.0% (HPLC)
Kūlana hoʻāʻo ʻOihana Kūlana
Hoʻohana Ka waena o Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai.

Pono:

1

FAQ:

Noi:

ʻO 3-(Trifluoromethyl) -5,6,7,8-tetrahydro- [1,2,4] triazolo [4,3-a] pyrazine Hydrochloride (CAS: 762240-92-6) he mea waena o Sitagliptin Phosphate Monohydrate ( CAS: 654671-77-9), he mea hoʻopaneʻe DPP4 koho i ka waha-bioavailable i ʻike ʻia ma o ka loiloi ʻana o kahi papa o nā mea hoʻopaneʻe DPP4 i loaʻa i ka β-aminoacid.Hoʻohaʻahaʻa ia i ka hana DPP4 ma ke ʻano hoʻomau ma hope o ka hoʻohana ʻana i hoʻokahi manawa i kēlā me kēia lā, mālama i nā pae holoʻokoʻa o GIP paʻa a me GLP1 ma hope o ka ʻai ʻana i nā haʻawina koʻikoʻi a mau loa a hoʻemi i nā pae glucose koko me ka piʻi ʻole o ka hypoglycaemia.Hoʻohana ʻia ʻo Sitagliptin Phosphate (STG) e mālama i ka DM type 2 no ka mea e hoʻomaikaʻi i ka mana glycemic ma o ka hoʻonui ʻana i nā pae o nā hormones incretin ikaika, GLP-1 (peptide-1) a me GIP (glucose-dependent insulinotropic peptide).Ua ʻae ʻia ʻo STG e ka FDA i ka makahiki 2006.

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou